| Company Name: |
Quality Control Solutions Ltd.
|
| Tel: |
0755-66853366 13670046396 |
| Email: |
orders@qcsrm.com |
| Products Intro: |
Product Name:13,14-dihydro-15(R)-Prostaglandin E1
CAS:201848-10-4
Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:13,14-dihydro-15(R)-Prostaglandin E1
CAS:201848-10-4
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
| Company Name: |
Jinan ponder chemical co. LTD
|
| Tel: |
0531-0000 |
| Email: |
thinklifescience@163.com |
| Products Intro: |
Product Name:201848-10-4
CAS:201848-10-4
Purity:99% HPLC Package:1KG;500G;100G;50G;1G
|
|
| | 13,14-DIHYDRO-15(R)-PROSTAGLANDIN E1 Basic information |
| Product Name: | 13,14-DIHYDRO-15(R)-PROSTAGLANDIN E1 | | Synonyms: | 13,14-DIHYDRO-15(R)-PROSTAGLANDIN E1;9-OXO-11ALPHA,15R-DIHYDROXY-PROSTAN-1-OIC ACID;13,14-dihydro-15(R)-PGE1;9-oxo-11α,15R-dihydroxy-prostan-1-oic acid;Prostan-1-oic acid, 11,15-dihydroxy-9-oxo-, (11α,15R)- (9CI) | | CAS: | 201848-10-4 | | MF: | C20H36O5 | | MW: | 356.5 | | EINECS: | | | Product Categories: | | | Mol File: | 201848-10-4.mol |  |
| | 13,14-DIHYDRO-15(R)-PROSTAGLANDIN E1 Chemical Properties |
| Boiling point | 541.4±35.0 °C(Predicted) | | density | 1.075±0.06 g/cm3(Predicted) | | solubility | DMF: >100 mg/ml (from PGE1); DMSO: >50 mg/ml (from PGE1); Ethanol: >50 mg/ml (from PGE1); PBS pH 7.2: >1.6 mg/ml (from PGE1) | | pka | 4.77±0.10(Predicted) |
| | 13,14-DIHYDRO-15(R)-PROSTAGLANDIN E1 Usage And Synthesis |
| Uses | 13,14-dihydro-15(R)-Prostaglandin E1 (13,14-dihydro-15(R)- PGE1) is an analog of 13,14-dihydro- PGE1 which has the hydroxyl group at C-15 in the unnatural R configuration[1]. | | Definition | ChEBI: 13,14-dihydro-15(R)-Prostaglandin E1 is a prostanoid. | | References | [1] Sinzinger H, et al. PGE1 and 13, 14-dihydro-PGE1 Increase Low-Density Lipoprotein Receptors and Improve Arterial Wall Lipid Metabolism//Prostaglandin E1: New Aspects on Pharmacology, Metabolism and Clinical Efficacy. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991: 39-48. |
| | 13,14-DIHYDRO-15(R)-PROSTAGLANDIN E1 Preparation Products And Raw materials |
|